FIELD: medicine.
SUBSTANCE: invention refers to a pharmaceutical composition exhibiting anticancer activity, containing disaccharide and a compound of formula
, a method for preparing said composition, a product containing said composition and a method of treating proliferative diseases by means of said composition.
EFFECT: higher anticancer activity of the preparations.
22 cl, 11 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ECTEINASCIDIN AND DISACCHARIDE-CONTAINING COMPOSITIONS | 2005 |
|
RU2382647C2 |
| PHARMACEUTICAL COMPOSITION OF NEUROPROTECTIVE ACTION FOR PARENTERAL APPLICATION ON BASIS OF HEXAMETHYLENEDIAMINE BIS-(N-MONOSUCCINYL-L-GLUTAMIL-L-LYSINE) IN LYOPHILIZED DOSAGE FORM | 2017 |
|
RU2678203C2 |
| DRUG FOR INJECTION BASED ON SAPONIN B4 PULSATILLA | 2017 |
|
RU2759382C2 |
| STABLE PHARMACEUTICAL PREPARATION BASED ON THE PD-1 ANTIBODY AND ITS USE IN MEDICINE | 2016 |
|
RU2731418C2 |
| PACKAGING AND METHOD OF ITS OBTAINING | 2019 |
|
RU2798169C2 |
| LYOPHILISED INJECTED PHARMACEUTICAL COMPOSTION OF SEMISYNTHETIC ALKALOIDS VINCA AND CARBOHYDRATES, STABLE AT ROOM TEMPERATURE | 2007 |
|
RU2449791C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING ANTIBODIES TO PCSK-9, AND ITS USE | 2018 |
|
RU2782792C2 |
| LYOPHILISED PREPARATION OF CYTOTOXIC DIPEPTIDES | 2012 |
|
RU2597154C2 |
| LYOPHILIZED LIPOSOMES | 2012 |
|
RU2780489C2 |
| LIOPHILIZED LIPOSOMES | 2012 |
|
RU2648753C2 |
